Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria

Impact of Long-Acting Calcium Channel Blockers on the Prognosis of Patients with Coronary Artery Disease with and without Chronic Kidney Disease: A Comparison of Three Drugs

(2013) Y Nitta et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Relation Between Kidney Function, Proteinuria, and Adverse Outcomes

(2010) Brenda R. Hemmelgarn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3–5 chronic kidney disease

(2009) Masanori Abe et al.   HYPERTENSION RESEARCH

The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

(2009)   HYPERTENSION RESEARCH

Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R

(2008) Osamu Akizuki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY